Related Experiment Video
Updated: Sep 11, 2025

Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
Everolimus therapy in an infant with Noonan syndrome with multiple lentigines
Mani Ram Krishna1, Usha Nandhini Sennaiyan1
1Department of Pediatric Cardiology, Tiny Hearts Hospital, Thanjavur, Tamil Nadu, India.
Abstract:
RASopathies are the most common underlying etiology in infants with hypertrophic cardiomyopathy. An improved understanding of the downstream molecular mechanisms of the disease has enabled us to target therapy for genetic abnormalities in human cancers with somatic mutations in the RASopathy genes. This therapy is now being extended to RASopathies, which are due to germline mutations in the same genes. We report an infant with Noonan syndrome with multiple lentigines who presented with symptomatic heart failure in infancy. Everolimus therapy over 1 year resulted in symptomatic improvement with no significant adverse clinical events.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Satellite Stem Cells and Muscular Dystrophy
Teratogenicity
Nephrotic Syndrome I : Introduction

